References
- Lundquist F, Tygstrup N, Winkler K, Mellemgaard K, Munck-Petersen S. Ethanol metabolism and production of free acetate in the human liver. J Clin Invest 1962; 41: 955–61
- Wartburg JP, Bethune JL, Vallee BL. Human liver-alcohol dehydrogenase. Kinetic and physicochemical properties. Biochemistry 1964; 3: 1775–82
- Crabb DW, Bosron WF, Li TK. Steady-state kinetic properties of purified rat liver alcohol dehydrogenase: application to predicting alcohol elimination rates in vivo. Arch Biochem Biophys 1983; 224: 299–309
- Ehrig T, Bosron WF, Li TK. Alcohol and aldehyde dehydrogenase. Alcohol Alcoholism 1990; 25: 105–16
- Lieber CS, DeCarli LM. Ethanol oxidation by hepatic microsomes: adaptive increase after ethanol feeding. Science 1968; 162: 917–8
- Lieber CS, DeCarli LM. Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo. J Biol Chem 1970; 245: 2905–12
- Asai H, Imaoka S, Kuroki T, Monna T, Funae Y. Microsomal ethanol oxidizing system activity by human hepatic cytochrome P450s. J Pharm Exp Ther 1996; 277: 1004–9
- Lieber CS, DeCarli LM. The role of hepatic microsomal ethanol oxidizing system (MEOS) for ethanol metabolism in vivo. J Pharm Exp Ther 1972; 181: 279–87
- Teschke R, Hasumura Y, Lieber CS. Hepatic microsomal alcohol-oxidizing system. Affinity for methanol, ethanol, propanol, and butanol. J Biol Chem 1975; 250: 7397–404
- Kalant H, Khanna JM, Endrenyi L. Effect of pyrazole on ethanol metabolism in ethanol-tolerant rats. Can J Physiol Pharmacol 1975; 53: 416–22
- Khanna JM, Kalant H. In vivo significance of the microsomal ethanol oxidizing system (MEOS). Adv Exp Med Biol 1977; 85A: 281–302
- Keiding S, Christensen NJ, Damgaard SE, Dejgård A, Iversen HL, Jacobsen A, et al. Ethanol metabolism in heavy drinkers after massive and moderate alcohol intake. Biochem Pharmacol 1983; 32: 3097–102
- Crabb DW, Bosron WF, Li T-K. Ethanol metabolism [review]. Pharmacol Ther 1987; 34: 59–73
- Norberg Å, Jones AW, Hahn RG, Gabrielsson JL. Role of variability in explaining ethanol pharmacokinetics; research and forensic applications [review]. Clin Pharmacokinet 2003; 42: 1–31
- Jones AW. Ultra-rapid rate of ethanol elimination from blood in drunken drivers with extremely high blood-alcohol concentrations. Int J Legal Med 2008; 122: 129–34
- Teschkle R, Gellert J. Hepatic microsomal ethanol-oxidizing system (MEOS): metabolic aspects and clinical implications [review]. Alcoholism: Clin Exp Res 1986; 10(Suppl6)20S–32S
- Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev 2004; 36: 511–29
- Mello T, Ceni E, Surrenti C, Galli A. Alcohol- induced hepatic fibrosis: role of acetaldehyde [review]. Mol Aspects Med 2008; 29: 17–21
- Keiding S, Johansen S, Midtbøll I, Rabøl A, Christiansen L. Ethanol elimination kinetics in human liver and pig liver in vivo. Am J Physiol 1979; 237: E316–24
- Bass L, Keiding S, Winkler K, Tygstrup N. Enzymatic elimination of substrates flowing through the intact liver. J Theor Biol 1976; 61: 393–409
- Keiding S, Johansen S, Winkler K, Tønnesen K, Tygstrup N. Michaelis–Menten kinetics of galactose elimination by the isolated perfused pig liver. Am J Physiol 1976; 320: 1302–13
- Keiding S, Sørensen M. Hepatic removal kinetics: importance for quantitative measurements of liver function. Textbook of hepatology: from basic science to clinical practice3rd edn, J Rodes, J-P Benhamou, JF Dufour, A Blei, J Reichen, M Rizzetto. Blackwell, Oxford 2007; 561–6
- Greenway CV, Lautt WW, Sitar DS. Hepatic blood flow: Estimation of clearances of very low dose infusions of ethanol in cats. Can J Physiol Pharmacol 1988; 66: 1191–7
- Winkler K, Bass L, Keiding S, Tygstrup N. Physiologic basis of clearance measurements in hepatology [review]. Scand J Gastroenterol 1979; 14: 439–48
- Tygstrup N. The galactose elimination capacity in relation to clinical and laboratory findings in patients with cirrhosis. Acta Med Scand 1964; 175: 290–300
- Tygstrup N. Effect of sites of blood sampling in determination of the galactose elimination capacity. Scand J Clin Lab Invest 1977; 18: 333–8
- Keiding S, Vilstrup H. Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis. Scand J Gastroenterol 2002; 37: 960–4
- Skak C, Keiding S. Methodological problems in the use of indocyanine green to estimate hepatic blood flow and ICG clearance in man. Liver 1987; 7: 155–62
- Nielsen NC. Correction for blank density caused by turbidity in human plasma. Scand J Clin Lab Invest 1965; 17: 165–70
- Nielsen NC. Spectrophotometric determination of indocyanine green in plasma especially with a view to an improved correction for blank density. Scand J Clin Lab Invest 1963; 15: 613–21
- Lundquist F. The determination of ethylalcohol in blood and tissues. Methods of biochemical analyses, D Glück. Interscience, New York 1959; 217–51
- Utne HE, Winkler K. Hepatic and extra-hepatic elimination of ethanol in cirrhosis with estimates of intra-hepatic shunts and Km for ethanol elimination. Scand J Gastroenterol 1980; 15: 297–304
- Buris L, Csabai G, Fodor M, Varga M. Increase in alcohol dehydrogenase and protein content of liver following chronic ethanol administration. FEBS Lett 1985; 183: 143–4
- Holund B, Poulsen H, Schlichting P. Reproducibility of liver biopsy diagnosis in relation to the size of the specimen. Scand J Gastroenterol 1980; 155: 329–35
- Bass L, Robinson P, Bracken AJ. Hepatic elimination of flowing substrates: the distributed model. J Theor Biol 1978; 72: 161–84
- Winkler K, Lundquist F, Tygstrup N. The hepatic metabolism of ethanol in patients with cirrhosis of the liver. Scand J Clin Lab Invest 1969; 23: 59–69